The epigenetic modifier CHD5 functions as a novel tumor suppressor for renal cell carcinoma and is predominantly inactivated by promoter CpG methylation
Zhenfang Du(Southeast University), Qian Tao(Zhejiang University)
Cited by 28
Related Papers
Mechanisms of receptor tyrosine kinase activation in cancer
|Molecular Cancer|2018|1.1k
The Ubiquitin Peptidase UCHL1 Induces G0/G1 Cell Cycle Arrest and Apoptosis Through Stabilizing p53 and Is Frequently Silenced in Breast Cancer
|PLoS ONE|2012|133
CaMKII-mediated Beclin 1 phosphorylation regulates autophagy that promotes degradation of Id and neuroblastoma cell differentiation
|Nature Communications|2017|97